NOVAREX Co.,Ltd. (KOSDAQ:194700)
South Korea · Delayed Price · Currency is KRW 15,200
+600 (4.11%)
At close: Apr 29, 2026
NOVAREX Market Cap
NOVAREX has a market cap or net worth of 256.31 billion as of April 30, 2026. Its market cap has increased by 50.04% in one year.
Market Cap
256.31B
Enterprise Value
244.06B
Revenue
404.26B
Ranking
n/a
PE Ratio
7.45
Stock Price
15,200.00
Market Cap Chart
Since November 14, 2018, NOVAREX's market cap has increased from 180.98B to 256.31B, an increase of 41.63%. That is a compound annual growth rate of 4.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 256.31B | 3.42% |
| Dec 30, 2025 | 247.83B | 86.67% |
| Dec 30, 2024 | 132.77B | -38.22% |
| Dec 28, 2023 | 214.90B | 19.61% |
| Dec 29, 2022 | 179.68B | -41.23% |
| Dec 30, 2021 | 305.72B | -1.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CellBion | 483.75B |
| HEM Pharma | 426.98B |
| DAE HWA Pharmaceutical | 262.92B |
| GREEN CROSS WellBeing | 246.48B |
| High Tech Pharm | 205.33B |
| Vivozon Pharmaceutical | 190.42B |
| OPTUS Pharmaceutical | 165.70B |
| Organoidsciences | 151.14B |